Table 1.
Characteristics of participants included in analyses of incident atrial fibrillation.
| MDCS | MESA | PREVEND | PROSPER* | BioVU | |
|---|---|---|---|---|---|
| No. total | 8,226 | 2,451 | 1,624 | 5,212 | 1,388 |
| No. incident AF | 190 | 76 | 34 | 503 | 229 |
| Age, years | 59±7 | 63±10 | 58±8 | 75±3 | 60±11 |
| Women | 4,275 (52) | 1,321 (52) | 770 (47) | 2,716 (52) | 678 (49) |
| Height, cm | 169±9 | 169±10 | 172±9 | 165±9 | 171±11 |
| Weight, kg | 75±14 | 79±16 | 80±14 | 73±13 | 86±22 |
| Systolic blood pressure, mmHg | 145±20 | 124±20 | 135±21 | 155±22 | 131±20 |
| Diastolic blood pressure, mmHg | 87±10 | 75±10 | 77±10 | 84±11 | 75±30 |
| History of smoking | 2,513 (31) | 1,401 (55) | 671 (41) | 1,388 (27) | 619 (45) |
| Antihypertensive medication | 1,799 (22) | 840 (33) | 362 (22) | 3,854 (74) | 1,339 (96) |
| History of diabetes | 542 (7) | 151 (6) | 98 (6) | 540 (10) | 359 (26) |
| History of heart failure | 39 (0.5) | 52 (2) | 4 (0.2) | NA | 161 (12) |
| History of myocardial infarction | 487 (9) | 63 (3) | 71 (4) | 697 (13) | 284 (20) |
Data presented as mean ± standard deviation, or No. (%)
*
Maximum follow-up in PROSPER was 4 years.